Ata uhi

Therapeutic Radionuclides in Nuclear Medicine

Dear Colleagues, Recently, the theranostic principle has been used with tumor receptor-specific radiopharmaceuticals containing therapeutic nuclides, such as 161Tb, 177Lu, 188Re, 212Pb, and 225Ac. The production mode, availability, and costs of radionuclides have a significant impact on their clinic...

Whakaahuatanga katoa

I tiakina i:
Hōputu: Online
Reo:Ingarihi
I whakaputaina: MDPI - Multidisciplinary Digital Publishing Institute 2025
Ngā marau:
IGF2R
osteosarcoma
image-based dosimetry RAPID
89Zr
177Lu
tissue cross-reactivity
PET/CT
90Y
PET
dosimetry
radionuclide therapy
quantitative accuracy
uncertainty analysis
MRT
scanner
multicenter
203Pb
212Pb
TOC
cell uptake
AR42 J
molar activity (AM)
neuroendocrine tumor (NET)
somatostatin receptor (SST2)
targeted alpha-therapy (TAT)
targeted alpha therapy
alpha particle therapy
PET imaging
SPECT imaging
targeted radionuclide therapy
theranostics
actinium-225
lanthanum-133
lead-212
lead-203
gold nanoparticles
[198Au]AuNPs
radioactive
tumor therapy
tumor angiogenesis
RGD peptide
225Ac
physical properties
production routes
theranostic application
cisplatin
radionuclides
alpha-emitter
cancer therapy
combined treatment
isobolograms
adrenocortical carcinoma
endoradiotherapy
IMAZA
alpha emitter
high let
theranostic
selective internal radionuclide therapy (SIRT)
90Y glass microspheres
hepatocellular carcinoma (HCC)
transarterial chemoembolization (TACE)
molecular radiotherapy
peptide receptor radionuclide therapy
neuroendocrine tumours
thema EDItEUR::A The Arts::AT Performing arts::ATD Theatre studies
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
thema EDItEUR::A The Arts::AV Music
Urunga tuihono:ONIX_20250220_9783725829385_498
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ipurangi

ONIX_20250220_9783725829385_498

Ngā tūemi rite